Baker Bros. Advisors LP Summit Therapeutics Inc. Transaction History
Baker Bros. Advisors LP
- $7.52 Billion
- Q2 2024
A detailed history of Baker Bros. Advisors LP transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 23,222,222 shares of SMMT stock, worth $485 Million. This represents 2.41% of its overall portfolio holdings.
Number of Shares
23,222,222Holding current value
$485 Million% of portfolio
2.41%Shares
4 transactions
Others Institutions Holding SMMT
# of Institutions
150Shares Held
66.3MCall Options Held
1.05MPut Options Held
1.07M-
Vanguard Group Inc Valley Forge, PA8.82MShares$184 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$165 Million0.0% of portfolio
-
State Street Corp Boston, MA4.12MShares$86.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.96MShares$61.9 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.04MShares$42.7 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.2B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...